Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)
- Author
- Erwin Woff, Pashalina Kehagias, Caroline Vandeputte, Tarek Kamoun, Thomas Guiot, Lieveke Ameye, Karen Geboes (UGent) , Thierry Delaunoit, Gauthier Demolin, Marc Peeters (UGent) , Lionel A. D'Hondt, Jos Janssens, Javier Carrasco, Stephane Holbrechts, Jean-Charles Goeminne, Jean-Luc Van Laethem, Philippe Vergauwe, Marianne Paesmans, Patrick Flamen and Alain Hendlisz
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8710002
- MLA
- Woff, Erwin, et al. “Baseline Cell-Free DNA (CfDNA) and Metabolic Tumor Volume (MTV) Independently Predict Outcome in Metastatic Chemorefractory Colorectal Cancer (MCRC).” JOURNAL OF CLINICAL ONCOLOGY, vol. 35, no. Supplement 15, 2017, doi:10.1200/JCO.2017.35.15_suppl.11569.
- APA
- Woff, E., Kehagias, P., Vandeputte, C., Kamoun, T., Guiot, T., Ameye, L., … Hendlisz, A. (2017). Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC). JOURNAL OF CLINICAL ONCOLOGY, 35(Supplement 15). https://doi.org/10.1200/JCO.2017.35.15_suppl.11569
- Chicago author-date
- Woff, Erwin, Pashalina Kehagias, Caroline Vandeputte, Tarek Kamoun, Thomas Guiot, Lieveke Ameye, Karen Geboes, et al. 2017. “Baseline Cell-Free DNA (CfDNA) and Metabolic Tumor Volume (MTV) Independently Predict Outcome in Metastatic Chemorefractory Colorectal Cancer (MCRC).” In JOURNAL OF CLINICAL ONCOLOGY. Vol. 35. https://doi.org/10.1200/JCO.2017.35.15_suppl.11569.
- Chicago author-date (all authors)
- Woff, Erwin, Pashalina Kehagias, Caroline Vandeputte, Tarek Kamoun, Thomas Guiot, Lieveke Ameye, Karen Geboes, Thierry Delaunoit, Gauthier Demolin, Marc Peeters, Lionel A. D’Hondt, Jos Janssens, Javier Carrasco, Stephane Holbrechts, Jean-Charles Goeminne, Jean-Luc Van Laethem, Philippe Vergauwe, Marianne Paesmans, Patrick Flamen, and Alain Hendlisz. 2017. “Baseline Cell-Free DNA (CfDNA) and Metabolic Tumor Volume (MTV) Independently Predict Outcome in Metastatic Chemorefractory Colorectal Cancer (MCRC).” In JOURNAL OF CLINICAL ONCOLOGY. Vol. 35. doi:10.1200/JCO.2017.35.15_suppl.11569.
- Vancouver
- 1.Woff E, Kehagias P, Vandeputte C, Kamoun T, Guiot T, Ameye L, et al. Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC). In: JOURNAL OF CLINICAL ONCOLOGY. 2017.
- IEEE
- [1]E. Woff et al., “Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC),” in JOURNAL OF CLINICAL ONCOLOGY, Chicago, IL, 2017, vol. 35, no. Supplement 15.
@inproceedings{8710002, articleno = {{11569}}, author = {{Woff, Erwin and Kehagias, Pashalina and Vandeputte, Caroline and Kamoun, Tarek and Guiot, Thomas and Ameye, Lieveke and Geboes, Karen and Delaunoit, Thierry and Demolin, Gauthier and Peeters, Marc and D'Hondt, Lionel A. and Janssens, Jos and Carrasco, Javier and Holbrechts, Stephane and Goeminne, Jean-Charles and Van Laethem, Jean-Luc and Vergauwe, Philippe and Paesmans, Marianne and Flamen, Patrick and Hendlisz, Alain}}, booktitle = {{JOURNAL OF CLINICAL ONCOLOGY}}, issn = {{0732-183X}}, language = {{eng}}, location = {{Chicago, IL}}, number = {{Supplement 15}}, title = {{Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)}}, url = {{http://doi.org/10.1200/JCO.2017.35.15_suppl.11569}}, volume = {{35}}, year = {{2017}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: